Charles W. Newton, the Chief Financial Officer of $LYEL, bought 200,000 shares of the company on 03-17-2025 for an estimated $111,620. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately inf%. Following this trade, they now own 200,000 shares of this class of $LYEL stock.
$LYEL Insider Trading Activity
$LYEL insiders have traded $LYEL stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LYEL stock by insiders over the last 6 months:
- CHARLES W. NEWTON (Chief Financial Officer) purchased 200,000 shares for an estimated $111,620
- LYNN SEELY (President and CEO) purchased 175,000 shares for an estimated $106,190
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LYEL Hedge Fund Activity
We have seen 52 institutional investors add shares of $LYEL stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DECHENG CAPITAL LLC added 11,909,341 shares (+inf%) to their portfolio in Q4 2024, for an estimated $7,621,978
- FORESITE CAPITAL MANAGEMENT V, LLC added 8,133,047 shares (+inf%) to their portfolio in Q4 2024, for an estimated $5,205,150
- VENBIO PARTNERS LLC added 7,102,190 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,545,401
- CITADEL ADVISORS LLC added 3,752,968 shares (+211196.8%) to their portfolio in Q4 2024, for an estimated $2,401,899
- ORBIMED ADVISORS LLC removed 2,982,378 shares (-49.0%) from their portfolio in Q4 2024, for an estimated $1,908,721
- RENAISSANCE TECHNOLOGIES LLC added 1,414,746 shares (+716.7%) to their portfolio in Q4 2024, for an estimated $905,437
- OPALEYE MANAGEMENT INC. removed 1,395,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $892,800
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
